通过TAAR1激活诱导甲基胺成的分子机制
Yun Lin1, Jiening Wang2, Fan Shi3
1Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, 92 Weijin Road, Nankai District, Tianjin 300072, China.
Journal of medicinal chemistry
|October 2, 2024
概括
研究人员阐明了与甲基胺 (METH) 结合的人类微氨基关联受体1 (TAAR1) 的结构. 这揭示了TAAR1如何识别和激活METH,为治疗药物滥用和神经障碍提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
背景情况:
- 微氨基关联受体1 (TAAR1) 是一种与G蛋白结合的受体,它结合微氨基,并与神经系统疾病有关.
- TAAR1是精神分裂症,抑郁症和药物滥用等疾病的潜在治疗标.
研究的目的:
- 确定与甲基胺 (METH) 结合的人类TAAR1-Gs蛋白质复合物的结构.
- 阐明METH识别和TAAR1激活的分子机制.
- 了解类似安非他胺的药物与TAAR1.1的结合.
主要方法:
- 进行X射线晶体学以确定TAAR1-Gs-METH复合物的结构.
- 功能性测试用于研究连接体结合和受体激活.
- 模拟分子动力学以研究药物结合机制.
主要成果:
- 确定了与METH结合的人类TAAR1-Gs蛋白质复合物的结构.
- 揭示了METH识别和TAAR1选择性的分子基础.
- 确定了一种独特的激活机制,涉及TM5和TM6中的疏水核.
结论:
- 这些发现为TAAR1的连接体识别和激活机制提供了详细的理解.
- 这种结构和机制的洞察力对于开发用于药物滥用和神经疾病的新疗法至关重要.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
447
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
447
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
167
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
167
Stimulants
162
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
162
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K


